Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liver fibrosis: Direct antifibrotic agents and targeted therapies
Detlef Schuppan, Muhammad Ashfaq–Khan, Ai Ting Yang, et al.
Matrix Biology (2018) Vol. 68-69, pp. 435-451
Closed Access | Times Cited: 374

Showing 1-25 of 374 citing articles:

Molecular and cellular mechanisms of liver fibrosis and its regression
Tatiana Kisseleva, David A. Brenner
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 3, pp. 151-166
Closed Access | Times Cited: 1297
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Maurizio Parola, Massimo Pinzani
Molecular Aspects of Medicine (2018) Vol. 65, pp. 37-55
Open Access | Times Cited: 899
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Natascha Roehlen, Émilie Crouchet, Thomas F. Baumert
Cells (2020) Vol. 9, Iss. 4, pp. 875-875
Open Access | Times Cited: 852
Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification
Saranya Chidambaranathan Reghupaty, Paul B. Fisher, Devanand Sarkar
Advances in cancer research (2020), pp. 1-61
Open Access | Times Cited: 625
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019
Bedair Dewidar, Christoph Meyer, Steven Dooley, et al.
Cells (2019) Vol. 8, Iss. 11, pp. 1419-1419
Open Access | Times Cited: 598
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Fanglong Wu, Jin Yang, Junjiang Liu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 451
Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis
Geoff Farrell, Jörn M. Schattenberg, Isabelle Leclercq, et al.
Hepatology (2018) Vol. 69, Iss. 5, pp. 2241-2257
Open Access | Times Cited: 277
The myofibroblast at a glance
Pardis Pakshir, Nina Noskovičová, Monika Lodyga, et al.
Journal of Cell Science (2020) Vol. 133, Iss. 13
Open Access | Times Cited: 220
Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver Fibrosis
Wei Chen, Aiting Yang, Jidong Jia, et al.
Hepatology (2020) Vol. 72, Iss. 2, pp. 729-741
Closed Access | Times Cited: 195
Cellular Mechanisms of Liver Fibrosis
Pragyan Acharya, Komal Chouhan, Sabine Weiskirchen, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 178
Collagen biology and non‐invasive biomarkers of liver fibrosis
M.A. Karsdal, Samuel J. Daniels, Signe Holm Nielsen, et al.
Liver International (2020) Vol. 40, Iss. 4, pp. 736-750
Open Access | Times Cited: 160
Fibroblast and myofibroblast activation in normal tissue repair and fibrosis
Fereshteh S. Younesi, Andrew Miller, Thomas H. Barker, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 8, pp. 617-638
Closed Access | Times Cited: 138
The inflammatory speech of fibroblasts
Ronen Schuster, Jason S. Rockel, Mohit Kapoor, et al.
Immunological Reviews (2021) Vol. 302, Iss. 1, pp. 126-146
Closed Access | Times Cited: 133
Mechanical communication in fibrosis progression
Long Yi, Yudi Niu, Kaini Liang, et al.
Trends in Cell Biology (2021) Vol. 32, Iss. 1, pp. 70-90
Closed Access | Times Cited: 126
Implant Fibrosis and the Underappreciated Role of Myofibroblasts in the Foreign Body Reaction
Nina Noskovičová, Boris Hinz, Pardis Pakshir
Cells (2021) Vol. 10, Iss. 7, pp. 1794-1794
Open Access | Times Cited: 113
Multipotent stromal cells: One name, multiple identities
H. S. Soliman, Marine Théret, R. Wilder Scott, et al.
Cell stem cell (2021) Vol. 28, Iss. 10, pp. 1690-1707
Open Access | Times Cited: 109
The Role of Myofibroblasts in Physiological and Pathological Tissue Repair
Ronen Schuster, Fereshteh S. Younesi, Maya Ezzo, et al.
Cold Spring Harbor Perspectives in Biology (2022) Vol. 15, Iss. 1, pp. a041231-a041231
Open Access | Times Cited: 108
Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities
Lili Ren, Xiaojun Li, Tingting Duan, et al.
Chemico-Biological Interactions (2022) Vol. 369, pp. 110289-110289
Closed Access | Times Cited: 86
Ten Years of Extracellular Matrix Proteomics: Accomplishments, Challenges, and Future Perspectives
Alexandra Naba
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 4, pp. 100528-100528
Open Access | Times Cited: 56
Liver Fibrosis Resolution: From Molecular Mechanisms to Therapeutic Opportunities
Qiying Pei, Qian Yi, Liling Tang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9671-9671
Open Access | Times Cited: 50
Mechanical regulation of myofibroblast phenoconversion and collagen contraction
Boris Hinz, Christopher A. McCulloch, Nuno M. Coelho
Experimental Cell Research (2019) Vol. 379, Iss. 1, pp. 119-128
Closed Access | Times Cited: 144
Improvements in Histologic Features and Diagnosis Associated With Improvement in Fibrosis in Nonalcoholic Steatohepatitis: Results From the Nonalcoholic Steatohepatitis Clinical Research Network Treatment Trials
Elizabeth M. Brunt, David E. Kleiner, Laura Wilson, et al.
Hepatology (2018) Vol. 70, Iss. 2, pp. 522-531
Open Access | Times Cited: 134
Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer
Joanne O’Rourke, Vandana Sagar, Tahir Shah, et al.
World Journal of Gastroenterology (2018) Vol. 24, Iss. 39, pp. 4436-4447
Open Access | Times Cited: 131
Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers
Leonard Kaps, Detlef Schuppan
Cells (2020) Vol. 9, Iss. 9, pp. 2027-2027
Open Access | Times Cited: 117
Golgi Apparatus-Targeted Chondroitin-Modified Nanomicelles Suppress Hepatic Stellate Cell Activation for the Management of Liver Fibrosis
Jingwen Luo, Pei Zhang, Ting Zhao, et al.
ACS Nano (2019) Vol. 13, Iss. 4, pp. 3910-3923
Closed Access | Times Cited: 114
Page 1 - Next Page

Scroll to top